Nobel Laureate David Baltimore to Speak at 35th Annual Calbiochem-UCSD Lectureship

Merck KGaA is proud to sponsor two lectures by Nobel Laureate Dr.
David Baltimore at the University of California-San Diego (UCSD) on
"Control of NF-(kappa)B" (Feb. 4, 2008) and "Engineering the Immune
System" (Feb. 6, 2008).

Dr. Baltimore is currently the Robert A. Millikan Professor of
Biology at the California Institute of Technology (CalTech). This
lectureship continues a 35 year-long tradition of Merck KGaA´s
Calbiochem(R) business partnering with UCSD to support the life
science research community.

In 1975, Dr. David Baltimore and Howard Temin were awarded the
Noble Prize in Medicine jointly with Renato Dulbecco for discovery of
reverse transcriptase, an enzyme critical to retroviruses such as HIV.
He is currently serving as president of AAAS and as co-chairman of the
National Academy Committee on Scientific Communication and National
Security. Authoring over 600 peer-reviewed articles to date, Dr.
Baltimore´s recent interests include control of inflammatory responses
and the use of gene therapy to treat HIV and cancer.

For more information on his background, see
http://www.merckbiosciences.com/html/EMD/davidbaltimore.html

Both lectures will begin at 4 P.M. in the Health Sciences
Auditorium of the Skaggs School of Pharmacy and Pharmaceutical
Sciences at UCSD, San Diego, CA.

Merck KGaA is well known for its Calbiochem(R) portfolio of
research reagents to study disease states and signal transduction.
Calbiochem(R) products include a wide range of enzyme inhibitors,
biochemicals, proteins, application-tested antibodies, and assay kits.

About EMD Chemicals Inc.

EMD Chemicals represents the North American chemical sector of
Merck KGaA, Darmstadt, Germany. Along with its sister company, EMD
Crop BioScience, it is an international organization with 1,110
employees and revenues of more than $US 360 million, providing
specialty chemicals for pharmaceutical, biotech, cosmetic, automotive,
plastics, electronics, agricultural and other industrial applications
and is also engaged in the development, manufacture and distribution
of a broad array of research reagents used for life science research.
EMD Chemicals is known in the market by its product brands including
Iriodin(R), Xirallic(R), Rona(R), Calbiochem(R), Novabiochem(R), and
Novagen(R), among others.

About Merck KGaA

Merck is a global pharmaceutical and chemical company with sales
of EUR 6.3 billion in 2006, a history that began in 1668, and a future
shaped by 30,962 employees in 61 countries. In 1917 the U.S.
subsidiary Merck & Co. was expropriated and has been an independent
company ever since.